Literature DB >> 30390068

Immune-cell crosstalk in multiple sclerosis.

Richard M Ransohoff.   

Abstract

Entities:  

Keywords:  Immunology; Medical research

Mesh：

Year:  2018        PMID： 30390068     DOI： 10.1038/d41586-018-07063-z

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.

Authors:  A Bitsch; J Schuchardt; S Bunkowski; T Kuhlmann; W Brück
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

Review 2.  The evidence justifying immunosuppression therapy in multiple sclerosis.

Authors:  J Mertin
Journal:  Proc R Soc Med       Date:  1977-12

Review 3.  B cells in multiple sclerosis.

Authors:  Hartmut Wekerle
Journal:  Autoimmunity       Date:  2017-02       Impact factor: 2.815

4.  Macrophages in multiple sclerosis.

Authors:  W Brück; N Sommermeier; M Bergmann; U Zettl; H H Goebel; H A Kretzschmar; H Lassmann
Journal:  Immunobiology       Date:  1996-10       Impact factor: 3.144

5.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Authors:  Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

Review 6.  The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.

Authors:  Jorge R Oksenberg; Sergio E Baranzini; Stephen Sawcer; Stephen L Hauser
Journal:  Nat Rev Genet       Date:  2008-06-10       Impact factor: 53.242

Review 7.  Nature, nurture, and microbes: The development of multiple sclerosis.

Authors:  H Wekerle
Journal:  Acta Neurol Scand       Date:  2017-11       Impact factor: 3.209

8.  HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.

Authors:  Malte Mohme; Christian Hotz; Stefan Stevanovic; Thomas Binder; Jar-How Lee; Michal Okoniewski; Thomas Eiermann; Mireia Sospedra; Hans-Georg Rammensee; Roland Martin
Journal:  Brain       Date:  2013-06       Impact factor: 13.501

9.  Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.

Authors:  Ivan Jelcic; Faiez Al Nimer; Jian Wang; Verena Lentsch; Raquel Planas; Ilijas Jelcic; Aleksandar Madjovski; Sabrina Ruhrmann; Wolfgang Faigle; Katrin Frauenknecht; Clemencia Pinilla; Radleigh Santos; Christian Hammer; Yaneth Ortiz; Lennart Opitz; Hans Grönlund; Gerhard Rogler; Onur Boyman; Richard Reynolds; Andreas Lutterotti; Mohsen Khademi; Tomas Olsson; Fredrik Piehl; Mireia Sospedra; Roland Martin
Journal:  Cell       Date:  2018-08-30       Impact factor: 41.582

Review 10.  Targeting Bruton's tyrosine kinase in B cell malignancies.

Authors:  Rudi W Hendriks; Saravanan Yuvaraj; Laurens P Kil
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716
View more
  6 in total

Review 1.  Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.

Authors:  Luc Van Kaer; Joshua L Postoak; Chuan Wang; Guan Yang; Lan Wu
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

Review 2.  [Ocrelizumab for treatment of multiple sclerosis].

Authors:  Jonas Graf; Philipp Albrecht; Norbert Goebels; Orhan Aktas; Hans-Peter Hartung
Journal:  Nervenarzt       Date:  2020-06-10       Impact factor: 1.214

Review 3.  Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1.

Authors:  Jonas Graf; Jan Mares; Michael Barnett; Orhan Aktas; Philipp Albrecht; Scott S Zamvil; Hans-Peter Hartung
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-12-16

4.  Comparative Profiling of TG2 and Its Effectors in Human Relapsing Remitting and Progressive Multiple Sclerosis.

Authors:  Damien D Pearse; Andrew B Hefley; Alejo A Morales; Mousumi Ghosh
Journal:  Biomedicines       Date:  2022-05-26

Review 5.  An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis.

Authors:  Annarita Del Gatto; Michele Saviano; Laura Zaccaro
Journal:  Molecules       Date:  2021-08-28       Impact factor: 4.411

6.  Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis.

Authors:  Meng Li; Hongping Chen; Pengqi Yin; Jihe Song; Fangchao Jiang; Zhanbin Tang; Xuehui Fan; Chen Xu; Yingju Wang; Yang Xue; Baichao Han; Haining Wang; Guozhong Li; Di Zhong
Journal:  Front Immunol       Date:  2021-12-07       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.